Details of the Drug

General Information of Drug (ID: DMARVRW)

• Drug Name: GS-1720

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus-1 infection	1C62	Phase 1	[1]

• Cross-matching ID: TTD ID: DIK3P4

References

• [1] ClinicalTrials.gov (NCT05585307) An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1. U.S.National Institutes of Health.